15th World Congress on Heart Disease
       

Cardiology Online

Home

Welcome

Scientific Committees

Timetable

Program Topics

Program

Opening Lecture

International Academy of Cardiology Awards

IAC Distinguished Fellowship Awards

Photos photos

General Information

Abstract Guidelines

Abstract Form

Instructions for the Preparation of Posters

Registration Form

Accommodation

Exhibition

Contact Us

Click here to download List of Scientific Presentations - Program (pdf)

Click here for Writing Instructions &
Sending your Article(s)
to Monduzzi Editore -
Medimond's Proceeding Book

 

 

final program

Sunday,
July 25, 2010
Monday,
July 26, 2010
Tuesday,
July 27, 2010
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions


Tuesday, July 27, 2010

8:00 - 13:00    
Board No.

 

 POSTER HALL

 

P501    Poster Session
NUCLEAR CARDIOLOGY/ POSITRON EMISSION TOMOGRAPHY/ CARDIAC CT AND MRI

 
1

EVALUATION OF CORONARY ARTERY DISEASE COMPLICATED BY THORACIC AORTIC DISEASE BY WIDE-VOLUME SCAN USING 320-ROW CT
K. Morishige, T. Yamawaki, H. Tashiro, St. Mary's Hospital, Kurume, Japan

 
2

RELATION OF LEFT ATRIAL BODY AND LEFT ATRIAL APPENDAGE VOLUMES WITH CLINICAL PATTERN OF AF
S. Verma, E. Charaf, N. Garg, Cardiology Consultants, Pensacola, FL, USA

 
3

IS IT SAFE TO USE REGADENOSON FOR PHARMACOLOGIC STRESS MYCOCARDIAL PERFUSION IMAGING IN END STAGE RENAL DISEASE PATIENTS ON DIALYSIS? FIRST CLINICAL REPORT OF 12 PATIENTS
Z. Husain, G. Palani, A. Karthikeyan, V. Karthikeyan,
K. Ananthasubramaniam St Joseph Mercy Oakland, Pontiac, MI, USA
 

 
4

CT ANGIOGRAPHY AND AORTIC ARCH ATHEROSCLEROSIS
D.J. Capampangan, A. Patel, S.J. Lester, L.A. Pearce, B.M. Demaerschalk, D.W. Dodick, T.E. Kiernan,
T.J. Ingall, M.I. Aguilar, Mayo Clinic, Phoenix, AZ, USA
 

 
5

DOES PERIPROCEDURAL MYONECROSIS AFTER MAIN VESSEL STENTING OF CORONARY BIFURCATIONS OCCUR? ASSESSMENT BY MEANS OF MRI DELAYED ENHANCEMENT
A. Michalek, D.I. Vassilev, R.J. Gil, T. Pawlowski,
T. Kulawik Central Hospital of the Internal Affairs and Adminstration Ministry, Poland
 

 
 

 

 
 

P502      Poster Session
ACUTE MYOCARDIAL INFARCTION / REPERFUSION THERAPY

 
6

EFFECT OF EARLIER DOOR TO BALLOON TIMES ON USE OF ADJUNCTIVE MEDICATIONS, AND RESULTANT PROCEDURAL SUCCESS IN STEMI
J.R. Cook, L.W. Klein, J. Chow, R. Marok, P.J. Stecy,
K. Magurany, Illinois Masonic Medical Center, Chicago, IL, USA

 
7

MECHANISM OF ELECTRICAL STIMULATION-INDUCED PRE- AND POST-CONDITIONING
X. Ren, Y. Liu, M. Tranter, M. Wilhide, T. Forde, L. Haar, K. Jones University of Cincinnati, OH, USA
 

 
8

THROMBUS ASPIRATION IN AMI PATIENTS AFTER SYSTEMIC TLT COMBINED WITH EMERGENCY PCI
D.G. Iosseliani, A.G. Koledinsky, D.G. Gromov,
N.V. Kuchkina, R.V. Zeynalov Moscow City Center of Interventional Cardioangiology, Moscow, Russia
 

 
9

NEIGHBORHOOD VARIATION IN RATE OF REVASCULARIZATION AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS IN NEW YORK CITY
A. Negassa, Albert Einstein College of Medicine, Bronx, NY, USA

 
 

 

 
 

P503      Poster Session
INTERVENTIONAL CARDIOLOGY II

 
10

PREDICTORS OF CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION IN STABLE ANGINA PATIENTS PRETREATED WITH STATINS
J. Veselka, P. Hajek, M. Maly, D. Zemanek, R. Adlova, D. Tesar, L. Martinkovicova, P. Tomasov, CardioVascular Center, University Hospital Motol, Prague, Czech Republic

 
11

OUTCOMES OF PCI IN NONAGENARIANS
C.N. Ionescu, M. Amuchastegui, S.C. Ionescu,
C.B. Marcu, A. Ghantous, S. Reddy, Hospital of Saint Raphael, New Haven, CT, USA
 

 
12

CLINICAL AND ELECTROCARDIOGRAPHIC CORRELATES OF NORMAL CORONARY ANGIOGRAPHY IN PATIENTS REFERED FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION
S.B. Prasad, D.A. Richards, N. Sadick, A.T. Ong,
A. Narayan, P. Kovoor Westmead Hospital, Sydney, Australia
 

 
13

IMPACT OF RISK FACTORS ON VASCULAR COMPLICATIONS AFTER PRECUTANEOUS CORONARY INTERVENTIONS IN SHAHEED RAJAEE HEART CENTER
A.A. Yusefi, H. Farshidi, M. Madani, F. Shakeryan,
H.R. Sanati, A. Firoozi, N. Salehi, Hormozgan University, Bandar Abbass, Hormozgan, Iran
 

 
14

THE FACTORS ASSOCIATED WITH STENOSIS DEGREE IN CORONARY BIFURCATIONS INFLUENCE RESTENOSIS RATES AFTER SINGLE STENT IMPLANTATION IN CORONARY BIFURCATION LESIONS
D.I. Vassilev, R.J. Gil, A. Michalek, T. Kulawik,
T. Pawlowski Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

 
15

LONG-TERM FOLLOW UP OF PATIENTS TREATED WITH PACLITAXEL-ELUTING STENTS WITH BIOSTABLE POLYMER VERSUS BIORESORBABLE POLYMER
L.A. Inigo-Garcia, C. Medina-Palomo, T. Gil-Jimenez,
O. Sanz-Vazquez, M. Pombo-Jimenez,
J.F. Munoz-Bellido, P. Chinchurreta-Capote,
B. Zaya-Ganfornina, J.R. Siles-Rubio, F. Ruiz-Mateas, Hospital Costa del Sol. Marbella, MA, Spain
 

 
 

 

 
 

P504    Poster Session
DIABETES MELLITUS, THE METABOLIC SYNDROME AND ATHEROSCLEROSIS: BASIC AND CLINICAL II

 
16

THE EFFECT OF INSULIN ON INTRACELLULAR NA+ HOMEOSTASIS IN ISOLATED CARDIOMYOCYTES FROM DIABETIC RATS
A. Bilginoglu, H.B. Kandilci, B. Turan, Ankara University, Ankara, Turkey

 
17

ASSOCIATION OF ADIPONECTIN AND THE HYPERTRIGLYCERIDEMIC-WAIST PHENOTYPE WITH IMPAIRED GLUCOSE TOLERANCE IN WOMEN
J. Methot, Y. Loucif, D. Brisson, D. Gaudet, Université de Montréal, Montréal, Canada
 

 
18

RELATIONSHIP BETWEEN SLEEP QUALITY AND METABOLIC SYNDROME AND INFLAMMATORY MARKERS IN MIDDLE-AGED MEN IN KOREA
J.H. Cho, S.G. Kang, E.J. Lee, S.W. Song, St.Vincent's Hospital, The Catholic University of Korea, Suwon, Gyeonggido, South Korea
 

 
19

ERYTHROCYTE FRAGILITY IS INCREASED IN THE LDL RECEPTOR DEFICIENT MOUSE MODEL
K. Navab, S. Hama, G. Hough, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
 

 
20

EFFECT OF THERAPEUTIC LIFESTYLE CHANGE ON HIGH DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS WITH METABOLIC SYNDROME
S.H. Kim, H.L. Lee, J.B. Seo, W.Y. Chung, J.H. Zo,
M.A. Kim, Seoul Metropolitan Boramae Hospital, Seoul National University, Seoul National
University Hospital, Seoul, Korea 

 
21

CARDIOVASCULAR HEALTH PROFILE OF PATIENTS ENROLLED IN A CLINIC BASED DIABETES PREVENTION PROGRAM
F.D. Fortuin, C. Kendall, J. Wisbey, R.T. Hurst,
S.J. Lester, S.B. Chism, R. Burke, M. Orban, S. Bersoux, C. Cook, Mayo Clinic Arizona, Phoenix, AZ, USA
 

 
22

GENDER AND INFLAMMATION IN INDIVIDUALS WITH THE METABOLIC SYNDROME
I. Shapira, S. Berliner, O. Rogowski, Tel Aviv Sourasky Medical Center, Tel Aviv, Sackler Faculty of Medicine,
Tel Aviv University, Tel Aviv, Israel 

 
 

 

 
 

P505      Poster Session
LIPID, LIPOPROTEIN DISORDERS AND CAD/ TREATMENT OF DYSLIPOPROTEINEMIA II

 
23

EXPERIMENTS ON THE MECHANISM OF FORMATION OF THE FATTY ACID HYDROPEROXIDES (HPODE AND HPETE)
D. Golchian, G. Hough, L. Vakili, S. Safarpoor, S. Hama David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

 
24

EFFICACY ON LIPOPROTEIN PROFILE AND TOLERABILITY OF SUSTAINED RELEASE FORMULATION OF SIMVASTATIN; IS THERE ANY
DIFFERENCE BETWEEN MORNING INTAKE OR NIGHTTIME GROUP?

S.H. Kim, H.Y. Lee, J.B. Seo, J.H. Zo, M.A. Kim,
Seoul Metropolitan Boramae Hospital, Seoul Metropolitan Bukbu Geriatric Hospital, Seoul National University, Seoul, Korea 

 
25

ANTI-INFLAMMATORY PEPTIDE COMBINATION ADDITIVELY RENDERS CARDIOMYOPATHY PATIENT PLASMA ANTI-INFLAMMATORY
O. Elboudwarej, J.B. Kim, S. Hama, G. Hough,
G. Fonarow David Geffen School of Medicine, Los Angeles, CA, USA
 

 
26

ACUTE REDUCTION OF LIPOPROTEIN A FOLLOWING LDL- APHERESIS MAY IMPROVE SYMPTOMS OF ANGINA
D.G. Bulchandani, P. Moriarty, University of Kansas School of Medicine, Kansas City, KS, USA
 

 
51

EFFECT OF EVERY OTHER DAY VERSUS DAILY DOSING OF ATORVASTATIN ON C-REACTIVE PROTEIN AND LIPID PROFILE
O.A. Rifaie, W.M. Nammas, A.M. Zahran, Ainshams University, Egypt
 

 
 

 

 
 

P506    Poster Session
DILATED CARDIOMYOPATHIES: VARIOUS ETIOLOGIES

 
27

THE DETERMINANTS OF RIGHT VENTRICULAR FAILURE IN PATIENTS ADMITTED WITH ACUTE RIGHT HEART FAILURE
R.B. Berkowitz, E. Alhaj, K. Satya, R.B. Manchikalapudi, S. Dadfarmay, Hackensack University Medical Center, Hackensack, NJ, USA

 
28

CEREBRAL HEMORRHAGE; PRECIPITATING EVENT FOR A TAKO-TSUBO-LIKE CARDIOMYOPATHY
A.R. Rahimi, M. Katayama, J. Mills, Mercer U. School of Medicine, Savannah, Georgia, USA

 
 

 

 
 

P507      Poster Session
DRUG THERAPY IN HEART FAILURE: BASIC AND CLINICAL

 
29

SSTR5 AND 1-AR BLOCKS SST MEDIATED INHIBITION OF cAMP AND SIGNALING IN RECEPTOR SPECIFIC MANNER
R.K. Somvanshi, S.A. War, N. Chaudhari, G. Kharmate, P.S. Rajput, D. Bakshi, X. Qiu, U. Kumar, The University of British Columbia, Vancouver, BC, Canada

 
30

MODULATION OF APOPTOTIC AND CALCINEURIN-MEDIATED NFAT DEPHOSPHORYLATION IN CELLS COEXPRESSING SSTR5 AND ß2-AR
R.K. Somvanshi, S.A. War, N. Chaudhari, G. Kharmate, P.S. Rajput, D. Bakshi, X. Qiu, U. Kumar, The University of British Columbia, Vancouver, BC, Canada
 

 
31

TREATMENT WITH L-CARNITINE SIGNIFICANTLY IMPROVES DIASTOLIC HEART FAILURE AND SYMPTOMS
A.R. Serati, M.R. Motamedi, S. Emami, P. Varedi,
M.R. Movahed
, The Southern Arizona VA Health Care System, AZ, USA
 

 
32

THIAMIN SUPPLEMENTATION IN PATIENTS WITH CHRONIC HEART FAILURE RECEIVING FULL MEDICAL TREATMENT
M. Mousavi, S. Namazi, M.R. Avadi Khatam-al-Anbia Hospital, Iran

 
 

 

 
 

P508   Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY: BASIC AND CLINICAL

 
33

A STRUCTURED AMIODARONE PROTOCOL FOR THE MANAGEMENT OF POST OPERATIVE ATRIAL FIBRILLATION IS EQUIVALENT TO INDIVIDUALIZED PHYSICIAN MANAGEMENT
M.J. Shih, M.G. Parikh, A. Khandelwal, R.S.D. Higgins, K. Krishnan, Rush University Medical Center, Chicago, IL, USA

 
34

THE PREVALENCE OF INTRA-VENTRICULAR CONDUCTION DELAY IN ATRIAL FIBRILLATION
E.A. Charaf, B.S. Abi-Saleh, P. Sultani, B. Omar,
S. Verma
, University of South Alabama, Mobile, Alabama, USA
 

 
35

SLOWING HEART RATE REDUCES INCIDENCE OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION - EXPERIMENTAL STUDY
L. Katsaros, N. Diakos, I. Pozios, E. Tseliou,
K. Malliaras, C. Pantsios, S. Sventzouri, N. Michelinakis,
J. Terrovitis, J. Nanas, University of Athens, Greece

 
36

ORAL ASCORBIC ACID IS EFFECTIVE IN THE PREVENTION OF ATRIAL FIBRILLATION AFTER CORONARY ARTERY BYPASS GRAFTING
M. Mousavi, M. Eslami, R. Sattarzadeh Badkoubeh,
H. Radmehr, M. Salehi, N. Tavakoli, M.R. Avadi, Tehran Heart Center,Tehran University of Medical Sciences, Tehran, Iran

 
37

ASSOCIATION OF WARFARIN USE WITH CHADS2 SCORE IN 441 PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND NO CONTRAINDICATIONS TO WARFARIN
H.M. Lai, W.S. Aronow, H.V. Desai, K. Gandhi,
S. Bakerywala, J. Laimuanpuii, M. Sharma, S.J. Peterson, New York Medical College, Valhalla, NY, USA
 

 
38

MULTIFACTORIAL QT INTERVAL PROLONGATION: THE RISK OF POLYPHARMACY
G.C. Digby, A.R. Perez Riera, R. Barbosa Barros,
L. de Sousa Belem, C. Fong, M. Methot, F. Femenia,
A. Baranchuk Department of Cardiology, Kingston General Hospital, Queen's University, Kingston, ON, Canada
 

 
39

WHAT ARE THE RISK FACTORS FOR DEVELOPING ATRIAL FIBRILLATION IN HIV INFECTED PATIENTS?
Y. Elnahar, J. Daoko, N. Gupta, F. Shamoon,
A. Al-dehneh
, Seton Hall University, Newark, NJ, USA
 

 
 

 

 
 

P509     Poster Session
ADVANCES IN CARDIAC SURGERY

 
40

SELECTIVE MITOCHONDRIAL TRANSLOCATION OF PHOSPHORYLATED PKC IN VIABLE MYOCYTES OVEREXPRESSING UROCORTIN AFTER CARDIOPLEGIC ARREST AND REPERFUSION
C. Chen-Scarabelli, S. Saravolatz, L.D. Saravolatz II,
G.M. Scarabelli, G. Chen, J. Di Rezze, L. Saravolatz,
T.M. Scarabelli
, St John Hospital, Wayne State University, Detroit, MI, USA

 
41

COMPARISON OF CORONARY ARTERY BYPASS GRAFTING VERSUS DRUG-ELUTING IMPLANTATION
P.P. Pollice, S.E. Saad, P.F. Pollice, F.A. Fabiani, University of Berne, Switzerland
 

 
42

LOWER TREND IN THE NATIONWIDE IN-HOSPITAL MORTALITY OF PATIENTS UNDERGOING CORONARY BYPASS SURGERY (CABG) IN THE UNITED STATES
M.R. Movahed, R.Ramaraj, M. Hashemzadeh, University of Arizona Sarver Heart Center, Tucson, AR, USA
 

 
43

CAROTID INTIMA-MEDIA THICKNESS BY B-MODE ULTRASOUND AS SURROGATE OF CORONARY ATHEROSCLEROSIS
M. Amato, P. Montorsi, A.L. Ravani, S. Galli,
P.M. Ravagnani, E. Tremoli, D. Baldassarre, Monzino Cardiology Center, IRCCS, Italy
 

 
44

PREVIOUS PERCUTANEUS CORONARY STENTING: A NEW RISK FACTOR IN CARDIAC SURGERY
J. Rubio, J. Sierra, L. Reija, B. Adrio, J. Garcia-Carro, J.M. Martinez-Cereijo, C. Delgado, Universitary Hospital Santiago de Compostela, Santiagio de Compostela, Spain

 
45

EFFECT OF CABG ON QT INTERVAL DISPERSION AS A MEASURE OF INHOMOGENEITY IN VENTRICULAR REPOLARIZATION
M. Nourizadeh, M. Alasti, S. Bahadoran,
M. Asadmoghadam Department of Cardiology, Imam Khomeini Hospital, Jondishapour University of Medical Sciences, Ahwaz, Iran
 

 
46

REVASCULARIZATION OUTCOMES ON THE JOINT CARDIOLOGY-CARDIOTHORACIC MULTIDISCIPLINARY TEAM (MDT) MEETING
W.K. Choo, R.A. Amersey, Whipps Cross University Hospital, London, UK
 

 
47

ASSESSMENT OF KIDNEY FUNCTION BY CYSTATIN C IN PATIENTS, AFTER CORONARY ARTERY BYPASS GRAFTING
M. Ster, T. Pintar, M. Tesovnik, J. Osredkar, M. Skitek, University Medical Centre, Ljubljana, Slovenia
 

 
 

 

 
 

P510      Poster Session
CARDIAC TRANSPLANTATION

 
48

THE USE OF IVUS FOR DIAGNOSIS AND MONITORING OF CARDIAC ALLOGRAFT VASCULOPATHY BY CARDIAC TRANSPLANT CENTERS IN THE UNITED STATES
E. Panczyk, J.C. Copeland, M.R. Movahed, University of Arizona Sarver Heart Center, Tucson, AR, USA
 

 
49

PROTAMINE CAN BE SAFELY ADMINISTERED FOR HEPARIN REVERSAL FOLLOWING IVUS IN CARDIAC TRANSPLANT PATIENTS
R. Arsanjani, A. Khitri, M. Hashemzadeh, M.R. Movahed, The Southern Arizona VA Health Care System, Tucson, AZ, USA
 

 
50

CNI - FREE IM IN CARDIAC TRANSPLANTATION - A SINGLE CENTER EXPERIENCE
M. Kondruweit, R. Tandler, M. Weyand, University of Erlangen, Bavaria, Germany
 

 
 

 

 

 

Sunday,
July 25, 2010
Monday,
July 26, 2010
Tuesday,
July 27, 2010
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions